GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (BOM:542650) » Definitions » Investments And Advances

Metropolis Healthcare (BOM:542650) Investments And Advances : ₹0 Mil (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare Investments And Advances?

Metropolis Healthcare's Investments And Advances for the quarter that ended in Mar. 2024 was ₹0 Mil.


Metropolis Healthcare Investments And Advances Historical Data

The historical data trend for Metropolis Healthcare's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare Investments And Advances Chart

Metropolis Healthcare Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Investments And Advances
Get a 7-Day Free Trial Premium Member Only - - - - -

Metropolis Healthcare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Metropolis Healthcare Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Metropolis Healthcare (BOM:542650) Business Description

Traded in Other Exchanges
Address
Hind Cycle Marg, 250-D, Udyog Bhavan, Behind Glaxo, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare (BOM:542650) Headlines

No Headlines